Clinical Trial: Anifrolumab Malignancy and Serious Infections Study

U.S., June 3 -- ClinicalTrials.gov registry received information related to the study (NCT07000110) titled 'Anifrolumab Malignancy and Serious Infections Study' on May 22.

Brief Summary: This is an observational study, in which the main research question is to evaluate the risk of malignancies and serious infections among moderate/severe SLE patients who receive anifrolumab compared with a comparable population of moderate/severe SLE patients on standard of care who do not initiate anifrolumab.

Study Start Date: May 31

Study Type: OBSERVATIONAL

Condition: Systemic Lupus Erythematosus

Intervention: DRUG: Anifrolumab

Anifrolumab prescribed per local practice

Recruitment Status: NOT_YET_RECRUITING

Sponsor: AstraZeneca

Disclaimer: Cu...